Anthera Pharma (ANTH) Tops Q1 EPS by 3c

Anthera Pharma (NASDAQ: ANTH) reported Q1 EPS of ($0.28), $0.03 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
• Aecon wins $1.7B share of Alberta power plant contract